17:12 IST
NSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reported Q1 FY27 consolidated revenue of ₹703.6 crore and EBITDA of ₹96.9 crore, reflecting 19% and 30% YoY growth respectively.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
1 announcement with these filters
Aarti Drugs reported Q1 FY27 consolidated revenue of ₹703.6 crore and EBITDA of ₹96.9 crore, reflecting 19% and 30% YoY growth respectively.